| Serial Number | 99355326 |
| Word Mark | ALGENBRAIN |
| Filing Date | Monday, August 25, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Monday, August 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | downloadable software using artificial intelligence and CRISPR technology for reverse engineering disease trajectory; downloadable software using artificial intelligence and CRISPR technology for analyzing and identifying dynamic gene expression changes and disease-driving RNA pathways; downloadable software using artificial intelligence and CRISPR technology for predicting gene expression changes during disease progression; downloadable software using artificial intelligence and CRISPR technology for precise gene editing and modulation; downloadable software using artificial intelligence and CRISPR technology for discovering gene targets for further evaluation and development; downloadable software using artificial intelligence and CRISPR technology for use in drug discovery; downloadable software using artificial intelligence and CRISPR technology for use in the identification, isolation, functional analysis, sequencing and mapping of genes; downloadable software using artificial intelligence and CRISPR technology for managing therapeutic discovery activities related to gene networking; downloadable software using artificial intelligence and CRISPR technology for identification, isolation, functional analysis, sequencing and mapping of genes |
| Goods and Services | development of software, artificial intelligence, CRISPR technology, therapeutics, and pharmaceuticals; development of software, artificial intelligence, CRISPR technology, therapeutics, and pharmaceuticals for managing therapeutic discovery activities related to gene networking; research and development in the field of drug discovery; drug discovery services; research and development of therapeutics to treat diseases utilizing a proprietary drug discovery platform; design and development of computer software that utilizes artificial intelligence and CRISPR technology; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for reverse engineering disease trajectory; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, CRISPR technology, machine learning, deep learning, science, chemistry, physics, and biology; computer modeling services; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for analyzing and identifying dynamic gene expression changes and disease-driving RNA pathways; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for predicting gene expression changes during disease progression; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for precise gene editing and modulation; providing temporary use of non-downloadable computer software using artificial intelligence and CRISPR technology for discovering gene targets for further evaluation and development; scientific research and product development in the field of genetics and drug discovery; scientific research, namely, identification, isolation, functional analysis, sequencing and mapping of genes; research and development in the field of biotechnology and gene networking technology for use in therapeutic discovery and development; scientific research and technological research in the fields of gene discovery, gene network informatics, and drug discovery; managing therapeutic discovery activities related to gene networking, namely, screening and prioritizing therapeutic agents for further evaluation and development, discovering novel biomarkers, validating biomarker strategies, gathering insights for patient selection and stratification for therapeutic treatment, and generating and storing therapeutic insights about the role a particular gene plays in a given disease and about the mechanism of action and therapeutic index of particular therapeutic agents |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 25, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 25, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Algen Biotechnologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94107 |
| Event Date | Event Description |
| Monday, August 25, 2025 | NEW APPLICATION ENTERED |
| Monday, August 25, 2025 | APPLICATION FILING RECEIPT MAILED |